Microbial Technologies Enhanced by Artificial Intelligence for Healthcare Applications
- PMID: 40100535
- PMCID: PMC11917392
- DOI: 10.1111/1751-7915.70131
Microbial Technologies Enhanced by Artificial Intelligence for Healthcare Applications
Abstract
The combination of artificial intelligence (AI) with microbial technology marks the start of a major transformation, improving applications throughout biotechnology, especially in healthcare. With the capability of AI to process vast amounts of biological big data, advanced microbial technology allows for a comprehensive understanding of complex biological systems, advancing disease diagnosis, treatment and the development of microbial therapeutics. This mini review explores the impact of AI-integrated microbial technologies in healthcare, highlighting advancements in microbial biomarker-based diagnosis, the development of microbial therapeutics and the microbial production of therapeutic compounds. This exploration promises significant improvements in the design and implementation of health-related solutions, steering a new era in biotechnological applications.
Keywords: artificial intelligence; drug; healthcare; microbial technology.
© 2025 The Author(s). Microbial Biotechnology published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Allegretti, J. R. , Khanna S., and Feuerstadt P.. 2023. “Practical Use of Fecal Microbiota Spores, Live BRPK for the Prevention of Recurrent Clostridioides difficile Infection.” American Journal of Gastroenterology 118: 2106–2108. - PubMed
-
- Baquero, F. , and Nombela C.. 2012. “The Microbiome as a Human Organ.” Clinical Microbiology and Infection 18: 2–4. - PubMed
-
- Chan, B. K. , Abedon S. T., and Loc‐Carrillo C.. 2013. “Phage Cocktails and the Future of Phage Therapy.” Future Microbiology 8: 769–783. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
